Potential of Polydatin Against Ischemia-Reperfusion Injury: New Insights from Pharmacological-Pathological Mechanism Associations
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s508851 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Zhicheng Sun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery, Xiangya Hospital of Central South University, Changsha, People's Republic of China. Hauptthemen laut MEDLINE: Glucosides, Reperfusion Injury, Stilbenes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Ischemia-reperfusion injury is a multi-tissue/organ susceptible and highly destructive disease. The complex pathological mechanisms of ischemia-reperfusion injury make its prevention and treatment highly challenging, and the development of novel drugs with pharmacological pleiotropy that can target multiple pathological mechanisms has become the focus of current drug research. Polydatin is a traditional Chinese medicine monomer with pleiotropic pharmacological effects, and existing research evidence suggests that polydatin has strong protective potential against ischemia-reperfusion injury. However, the mechanism of polydatin against ischemia-reperfusion injury is still unclear. In this review, the extensive pharmacological-pathological mechanism associations between polydatin and ischemia-reperfusion injury have been described from the perspectives of inflammatory response, oxidative stress, apoptosis, autophagy, ferroptosis, and cellular pyroptosis, which will provide references to the basic and applied research of polydatin in the field of ischemia-reperfusion injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Spine Surgery, Xiangya Hospital of Central South University, Changsha, People's Republic of China.
- Hunan Engineering Laboratory of Advanced Artificial Osteo-Materials, Xiangya Hospital, Central South University, Changsha, People's Republic of China.
- National Clinical Research Center of Geriatric Disorders, Xiangya Hospital of Central South University, Changsha, People's Republic of China.
Zitieren
APA
Sun, Z., Wang, X., & Pang, X. (2025). Potential of Polydatin Against Ischemia-Reperfusion Injury: New Insights from Pharmacological-Pathological Mechanism Associations. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s508851
Vancouver
Sun Z, Wang X, Pang X. Potential of Polydatin Against Ischemia-Reperfusion Injury: New Insights from Pharmacological-Pathological Mechanism Associations. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s508851
BibTeX
@article{Sun2025,
author = {Sun, Zhicheng and Wang, Xiyang and Pang, Xiaoyang},
title = {Potential of Polydatin Against Ischemia-Reperfusion Injury: New Insights from Pharmacological-Pathological Mechanism Associations},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s508851}
}
EUVIMED